These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1499626)

  • 1. Topical chemoprophylaxis of superficial bladder cancer with mitomycin C and adjuvant hyaluronidase.
    Höbarth K; Maier U; Marberger M
    Eur Urol; 1992; 21(3):206-10. PubMed ID: 1499626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4'-epidoxorubicin versus mitomycin C intravesical chemoprophylaxis of superficial bladder cancer.
    da Silva FC; Ferrito F; Brandão T; Santos A
    Eur Urol; 1992; 21(1):42-4. PubMed ID: 1606981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metaphylactic effect of mitomycin C with and without hyaluronidase after transurethral resection of bladder cancer: randomized trial.
    Maier U; Baumgartner G
    J Urol; 1989 Mar; 141(3):529-30. PubMed ID: 2493098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT; Yildirim U; Zorlu F; Ozen H
    J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term follow-up.
    El-Ghobashy S; El-Leithy TR; Roshdy MM; El-Ganzoury HM
    J Egypt Natl Canc Inst; 2007 Jun; 19(2):121-6. PubMed ID: 19034342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intravesical mitomycin C on the recurrence of superficial (Ta-T1) bladder cancer. A Hungarian Multicenter Study.
    Kondás J; Kiss L; Határ A; Kiss A; Lukács T; Szeldeli P; Törzsök F; Bodrogi I
    Int Urol Nephrol; 1999; 31(4):451-6. PubMed ID: 10668939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M; McGarry R; Kupelnick B
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of bladder wash cytology in the follow-up of patients with bladder carcinoma receiving intravesical chemoprophylaxis with mitomycin C.
    Hörbarth K; Maier U; Susani M
    Eur Urol; 1991; 20(2):93-6. PubMed ID: 1752281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A prospective and randomized study of the complete response, index of recurrences and progression in superficial bladder carcinoma treated with mitomycin C alone versus mitomycin C and BCG alternatively].
    Gelabert-Mas A; Arango Toro O; Bielsa Gali O; Lladó Carbonell C
    Arch Esp Urol; 1993 Jun; 46(5):379-82. PubMed ID: 8342972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitomycin C plasma levels after intravesical instillation with and without hyaluronidase.
    Maier U; Baumgartner G
    J Urol; 1986 Apr; 135(4):845-6. PubMed ID: 3083122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prophylactic intravesical instillation therapy in patients with superficial bladder cancer--results of a randomized prospective study].
    Tsushima T; Nasu Y; Abeki N; Noda M; Saika T; Ohmori H; Kobashi K; Ozaki Y; Matsumura Y; Tanahashi T
    Nihon Hinyokika Gakkai Zasshi; 1992 Aug; 83(8):1314-21. PubMed ID: 1405170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?
    Wu WJ; Ke HL; Yang YH; Li CC; Chou YH; Huang CH
    J Urol; 2010 Jan; 183(1):56-61. PubMed ID: 19913833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term effects on recurrence and mortality in superficial urothelioma of the bladder treated with endovesical chemotherapy].
    Ferraris V; Serao A; Buffa G
    Minerva Urol Nefrol; 1999 Jun; 51(2):95-101. PubMed ID: 10429419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term observation after intravesical metaphylaxis with mitomycin C in patients with superficial bladder tumors.
    Maier U; Höbarth K
    Urology; 1991 May; 37(5):481-2. PubMed ID: 1902606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of age on outcomes of patients with non-muscle-invasive bladder cancer treated with immediate postoperative instillation of mitomycin C.
    Xylinas E; Kent M; Dabi Y; Rieken M; Kluth LA; Al Hussein Al Awamlh B; Ouzaid I; Pycha A; Comploj E; Svatek RS; Lotan Y; Karakiewicz PI; Holmang S; Shariat SF
    Urol Oncol; 2018 Mar; 36(3):89.e1-89.e5. PubMed ID: 29221642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological changes due to intravesical instillation of mitomycin C.
    Castillo OA; Landerer E; Feria-Flores M; Vidal-Mora I; Franco C
    Arch Esp Urol; 2012 Jun; 65(5):578-82; discussion 582. PubMed ID: 22732786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitomycin C in multiple superficial bladder tumors: short-term therapy, long-term results.
    Milani C; Bassi P; Meneghini A; Garbeglio A; Zattoni F; Piazza N; Maruzzi D; Drago-Ferrante GL; Pagano F
    Urol Int; 1992; 48(2):154-6. PubMed ID: 1585510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical mitomycin C for superficial transitional cell carcinoma.
    Bolenz C; Cao Y; Arancibia MF; Trojan L; Alken P; Michel MS
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1273-82. PubMed ID: 16925493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat transurethral resection lowers recurrence rates in T1 bladder tumors, even after intravesical mitomycin C.
    Oosterlinck W
    Nat Clin Pract Urol; 2006 Nov; 3(11):582-3. PubMed ID: 17088923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.